Global Hematology Instrument Market Research Report 2022

 Hematology instruments are machines that analyze blood. Used in medical labs, hematology instruments can do blood counts, detect proteins or enzymes, and help to diagnose illnesses or genetic defects. 
Due to the COVID-19 pandemic, the global Hematology Instrument market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hematology Instrument market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hematology Instrument landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Analyzers accounting for % of the Hematology Instrument global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital/Clinics segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Hematology Instrument include HORIBA, Abbott Laboratories, Siemens, Bio-Rad Laboratories, Danaher, BD, Alere, Roche and Sekisui, etc. In terms of revenue, the global 3 largest players have a % market share of Hematology Instrument in 2021.
This report focuses on Hematology Instrument volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hematology Instrument market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Hematology Instrument Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Analyzers
Coagulation Instrument
Other
Segment by Application
Hospital/Clinics
Independent Diagnostic
Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
HORIBA
Abbott Laboratories
Siemens
Bio-Rad Laboratories
Danaher
BD
Alere
Roche
Sekisui
Axis-Shield
Chrono-Log

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports